Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin

Acta Pharmacologica Sinica

Volumn 28, Issue 5, 2007, Pages 744-750

  Ji, Ying ^a   Liu, Chen ^a   Pei, Yuan Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Absorption; Drug delivery system; Histopathology examination; Hypoglycemic effect; Minimal surface tension; Pharmacodynamics; Pharmacokinetics; Pulmonary; Pulmonary edema index

Indexed keywords

INSULIN; INSULIN 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOCHOLINE 1 HEXADECANOL TYLOXAPOL CONJUGATE; INSULIN 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOCHOLINE LECITHIN PALMITIC ACID CONJUGATE; INSULIN 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOCHOLINE LEVO ALPHA PHOSPHATIDYL DEXTRO LEVO GLYCEROL SODIUM SALT CONJUGATE; INSULIN 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOCHOLINE TYLOXAPOL CONJUGATE; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INSTILLATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IN VIVO STUDY; LUNG ALVEOLUS SURFACE TENSION; LUNG EDEMA; LUNG INJURY; MALE; NONHUMAN; RAT;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; DRUG CARRIERS; INSULIN; LUNG; PARTICLE SIZE; PULMONARY EDEMA; PULMONARY SURFACTANTS; RATS; RATS, WISTAR;

EID: 34247641223     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00513.x     Document Type: Article

References (20)

1. Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res 2001 2 : 198 209.
2. Merrill JD, Ballard RA. Pulmonary surfactant for neonatal respiratory disorders. Curr Opin Pediatr 2003 15 : 149 54.
3. Erpenbeck VJ, Hagenberg A, Dulkys Y, Elsner D, Balder R, Krentel H, et al. Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma. Am J Respir Crit Care Med 2004 169 : 578 86.
4. Van't Veen A, Gommers D, Mouton JW, Kluytmans JA, Krijt EJ, Lachmann B. Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity. Br J Pharmacol 1996 118 : 593 8.
5. Katkin JP, Husser RC, Langston C, Welty SE. Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum Gene Ther 1997 8 : 171 6.
6. Jiang ZQ, Sun GM, Ma YM. Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates. Acta Pharmacol Sin 1997 18 : 182 4.
7. Mitra R, Pezron I, Li Y, Mitra AK. Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int J Pharm 2001 217 : 25 31.
8. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977 43 : 198 203.
9. Ji Y, Pei YY. Primary study of artificial pulmonary surfactant as carrier of insulin pulmonary delivery. Chin Pharm J 2006 41 : 766 8.
10. Paddy JF. Surface tension. Part III. Tables relating the size and shape of liquid drops to the surface tension. In Matijevic E, editor. Surface and colloid science. New York : Wiley-Interscience 1969. p 151 97.
11. Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002 249 : 139 47.
12. Lu J, Ji Y, Jiang ZQ. Study on the bioavailability and initial investigation on the rat following pulmonary delivery of insulin lipid suspension. Chin J Biochem Pharm 2002 23 : 271 4.
13. Zhang Q, Shen ZC, Tsuneji N. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 2001 218 : 75 80.
14. Kharasch VS, Sweeney TD, Fredberg J, Lehr J, Damokosh AI, Avery ME, et al. Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am Rev Respir Dis 1991 144 : 909 13.
15. Enhorning G. Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp Biochem Physiol A Mol Integr Physiol 2001 129 : 221 6.
16. Tanaka Y, Takei T, Aiba T, Masuda K, Kiuchi A, Fujiwara T. Development of synthetic lung surfactants. J Lipid Res 1986 27 : 475 85.
17. Latallo JFK, Chen CL, Eichman J, Bielinska AU, Baker JR. Enhancement of endrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro. Biochem Biophys Res Commun 1999 264 : 253 61.
18. Lewis JF, Brackenbury A. Role of exogenous surfactant in acute lung damage. Crit Care Med 2003 31 : S324 8.
19. Palmblad M, Gustafsson M, Curstedt T, Johansson J, Schurch S. Surface activity and film formation from the surface associated material of artificial surfactant preparations. Biochim Biophys Acta 2001 1510 : 106 17.
20. Park SY, Hannemann RE, Franses EI. Dynamic tension and adsorption behavior of aqueous lung surfactants. Colloids Surf B Biointerfaces 1999 15 : 325 38.